KRISTEN BLACK: Open Payments
NPI 1730767302 · HAGERSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 21 payments from 9 companies in 2025. Trend: 2023 $55 · 2024 $92 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $79 |
| Lilly USA, LLC | 3 | $70 |
| Novo Nordisk Inc | 3 | $66 |
| GlaxoSmithKline, LLC. | 3 | $64 |
| ABBVIE INC. | 3 | $50 |
| Seqirus USA Inc | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: SHINGRIX, BREZTRI, Fluad, JARDIANCE, Ozempic, VRAYLAR, AIRSUPRA, KISUNLA.
Industry payments across MD — which companies pay providers there.
